HL9: 5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide

HL9 is a Ligand Of Interest in 6T30 designated by the Author


Best-fitted instance in this entry
Other instances in this entry
Best-fitted instance in this entry
Best-fitted PDB instances with same target (top 5)
Best-fitted instance in this entry
Best-fitted PDB instances with different target (top 5)
IdentifierRanking for goodness of fit Ranking for geometry Real space R factor Real space correlation coefficient RMSZ-bond-length RMSZ-bond-angleOutliers of bond length Outliers of bond angle Atomic clashesStereochemical errorsModel completenessAverage occupancy
6T30_HL9_B_201 77% 30% 0.107 0.9451.07 1.7 3 800100%1
6T30_HL9_A_201 76% 46% 0.112 0.9470.88 1.21 1 600100%1
6T31_HL9_A_201 99% 55% 0.058 0.990.51 1.2 - 500100%1
6T1E_HL9_A_405 97% 38% 0.077 0.991.14 1.27 3 400100%1
6T1K_HL9_A_201 94% 42% 0.084 0.9850.57 1.67 - 610100%1
6T32_HL9_A_201 92% 43% 0.086 0.9750.68 1.5 - 600100%1
6T2L_HL9_A_201 89% 54% 0.108 0.9880.6 1.15 - 600100%1
6T2Z_HL9_B_201 88% 54% 0.098 0.9720.58 1.2 - 400100%1